We are live on ! Find out more
CCM

Camber Capital Management Portfolio holdings

AUM $1.07B
1-Year Est. Return 8.19%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
-8.19%
3 Year Est. Return
+26.6%
5 Year Est. Return
+54.57%
10 Year Est. Return
+164.72%
AUM
$1.13B
AUM Growth
+$180M
Cap. Flow
+$94.7M
Cap. Flow %
8.35%
Top 10 Hldgs %
56.52%
Holding
45
New
11
Increased
9
Reduced
8
Closed
9

Top Buys

Rank Stock Value
1
THC icon
Tenet Healthcare
THC
+$47.9M
2
MRK icon
Merck
MRK
+$47.4M
3
UNH icon
UnitedHealth
UNH
+$46.7M
4
ARIA
Ariad Pharmaceuticals Inc
ARIA
+$28.3M
5
EW icon
Edwards Lifesciences
EW
+$23.7M

Top Sells

Rank Stock Value
1
CAH icon
Cardinal Health
CAH
+$39.1M
2
MAKO
MAKO SURGICAL CORP COM
MAKO
+$35.4M
3
GIVN
GIVEN IMAGING LTD
GIVN
+$28.8M
4
AZN icon
AstraZeneca
AZN
+$26M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$23.6M

Sector Composition

Rank Sector Weight
1 Healthcare 85.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNTA
26
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$14.1M 1.25%
800,000
– –
GNMK
27
DELISTED
GenMark Diagnostics, Inc
GNMK
$12.6M 1.12%
950,000
– –
NXTM
28
DELISTED
NxStage Medical Inc.
NXTM
$8.21M 0.72%
+820,535
New +$9.31M
PLX icon
29
Protalix BioTherapeutics
PLX
$191M
$7.78M 0.69%
200,000
+21,000
+12% +$884K
BIOL
30
DELISTED
Biolase, Inc.
BIOL
$7.65M 0.67%
217
– –
GERN icon
31
Geron
GERN
$828M
$7.11M 0.63%
+1,587,000
New +$6.81M
XNPT
32
DELISTED
XENOPORT, INC.
XNPT
$5.75M 0.51%
1,000,000
+190,057
+23% +$1.03M
DSCI
33
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
$5.38M 0.47%
497,000
-453,000
-48% -$5.26M
TRNX
34
DELISTED
TORNIER N V SHARES (NLD)
TRNX
$4.7M 0.41%
+250,000
New +$4.71M
BLUE
35
DELISTED
bluebird bio
BLUE
$4.34M 0.38%
15,973
+4,393
+38% +$1.23M
GYRE icon
36
Gyre Therapeutics
GYRE
$641M
$768K 0.07%
+235
New +$926K
AZN icon
37
AstraZeneca
AZN
$263B
– –
-500,000
Closed -$26M
CAH icon
38
Cardinal Health
CAH
$53.9B
– –
-750,000
Closed -$39.1M
SRPT icon
39
Sarepta Therapeutics
SRPT
$1.57B
– –
-500,000
Closed -$23.6M
MGLN
40
DELISTED
Magellan Health Services, Inc.
MGLN
– –
-175,000
Closed -$10.5M
WMGI
41
DELISTED
Wright Medical Group Inc
WMGI
– –
-711,000
Closed -$18.5M
ANTH
42
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
– –
-50,000
Closed –
ITMN
43
DELISTED
INTERMUNE INC
ITMN
– –
-500,000
Closed -$7.68M
GIVN
44
DELISTED
GIVEN IMAGING LTD
GIVN
– –
-1,500,000
Closed -$28.8M
MAKO
45
DELISTED
MAKO SURGICAL CORP COM
MAKO
– –
-1,200,000
Closed -$35.4M
1
2

Similar funds

PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
NRD
Nebula Research & Development New York $1.17B AUM 15.19% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return
CCP
Camelot Capital Partners Laguna Beach, California $686M AUM 163.55% 1-Year Est. Return

Camber Capital Management's Q4 2013 Portfolio in Review

As of Q4 2013, Camber Capital Management held 45 positions worth $1.13B, up 19% from $954M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Camber Capital Management deployed $94.7M of net new capital in Q4 2013, opening 11 new positions and adding to 9 existing holdings. Its largest new stake was Tenet Healthcare: 1,100,000 shares worth $46.3M.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, up from 78% a quarter earlier.

On the sell side, the largest reduction was Hologic, an estimated $16.5M trimmed.

  • Camber Capital Management's largest Q4 2013 buy was Tenet Healthcare: 1,100,000 shares worth $46.3M.
  • Camber Capital Management added most to HCA Healthcare in Q4 2013, an estimated $23.1M increase.
  • Camber Capital Management's biggest Q4 2013 reduction was Hologic, cutting an estimated $16.5M.
  • Camber Capital Management fully exited Cardinal Health in Q4 2013, selling an estimated $39.1M.
  • Camber Capital Management's ten largest holdings make up 57% of its $1.13B portfolio in Q4 2013.
  • Camber Capital Management opened 11 new positions and closed 9 in Q4 2013.
  • Camber Capital Management's portfolio value rose 19% quarter-over-quarter to $1.13B.

Based on Camber Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.